- Open Access
Autophagy is associated with cell fate in the process of macrophage-derived foam cells formation and progress
© The Author(s). 2016
Received: 2 June 2016
Accepted: 18 July 2016
Published: 30 July 2016
Autophagy participates in plaque formation and progression; however, its association with foam cells’ fate is unknown. To investigate autophagy features and its effect on the fate of different-stage macrophage foam cells (FCs). Different-stage FCs were obtained through incubation of THP-1 macrophages (THP-M) with oxidized low-density lipoprotein LDL (oxLDL, 80 μg/mL) for various durations (0–72 h). Autophagy in THP-1 macrophage FCs and in apoE−/− mice was regulated by Rapamycin (80 ug/mL) or 3-MA (10 mM). Lipid droplet accumulation, LC3 I/II, P62 expression level, and autophagic flux were measured. Vascular ultrasound, TUNEL, IHC, and DHE staining were used to detect the artery plaques in apoE−/− mice.
In early-stage FCs, the amount of autophagosomes gradually increased, and autophagic flux intensity accelerated, but in mid-late stage FCs, autophagic flux was suppressed. For early stage FCs, treatment with autophagy activator rapamycin markedly decreased intracellular lipid content and prevented them from transforming into foam cells, while the autophagy inhibitor 3-MA considerably increased the intracellular lipid-droplet accumulation. During the process of foam cell development, upregulating autophagy not only reduced intracellular lipid-droplet accumulation, but also inhibited cell apoptosis through clearing dysfunctional mitochondria and lowering intracellular ROS level. The in vivo experiments produced consistent results that rapamycin administration in apoE−/− mice reduced the death rate of macrophages and delayed plaque progression.
The fate of macrophage FCs was associated with autophagy. Early autophagy enhancement inhibits the formation and progression of macrophage FCs and prevents atherosclerosis.
Autophagy is an evolutionarily conserved mechanism and the only physiological self-protective process through which organisms remove damaged or unwanted intracellular materials, including protein aggregates, lipid droplets, dysfunctional mitochondria, and other damaged intracellular organelles. The autophagic process is classically considered to be a pathway contributing to cellular homeostasis and adaptation to stress [1, 2]. Under the action of stress factors, basal autophagy may act as a pro-survival mechanism in an adverse environment [3, 4]. However, dysfunctional autophagy is associated with human disease. Defects in autophagy have been implicated in the pathogenesis of cancers, heart failure, cancer, neurodegeneration , and inflammatory diseases [6–8]. However, little is known about the role of autophagy in atherosclerosis.
A limited number of clinical studies have shown that autophagic markers are co-localized with macrophages in atherosclerotic plaques, and autophagy is impaired in the advanced stages of atherosclerosis; its deficiency induced lethal accumulation of cholesterol crystals and promoted atherosclerosis [9–11]. Stent-based delivery of the mTOR inhibitor everolimus promotes a stable plaque phenotype. However, the direct evidence indicating the role of autophagy is insufficient. Monocytes/macrophages are the predominant cell type expressing autophagy markers in the plaque . Several basic examinations also revealed that mice with a macrophage-specific deletion of the essential autophagy gene Atg5 developed plaques with increased apoptosis and oxidative stress and exhibited enhanced plaque necrosis , suggesting that autophagy is involved in AS pathology. Nevertheless, little is known about the regulation and mechanism associated with autophagy in the pathogenesis of atherosclerosis [10, 14, 15]. There are still some important questions to be elucidated, including changes in autophagy with AS progression, critical time points for correcting dysfunctional autophagy, and the effective regulation of autophagy to achieve a positive effect in inhibiting atheroma progression.
The present study was designed to address these issues using oxidative low-density lipoproteins (ox-LDL)-treated THP-1 macrophages and high-fat–fed Apo E −/− mice. We investigated the characteristics of autophagy at different stages of the development of THP-1 macrophage (THP-M)-derived foam cells and explored its mechanism of action and effect on middle-late foam cell viability. Mechanistically, this process, in part, involves mitochondrial oxidative stress and cell apoptosis. In Apo E −/− mice, the suitable upregulation of autophagy delays the progress of atherosclerotic plaques.
Culture and differentiation of THP-1-derived macrophages
Ox-LDL-treated THP-1 macrophage is a commonly used model in the studies on autophagy associated with atherosclerosis. Initially, THP-1 cell (ATCC, Manassas, VA, USA) was cultured in RPMI-1640 medium (Invitrogen, San Diego, CA, USA) supplemented with 20 U/mL penicillin (Invitrogen), 20 μg/mL streptomycin (Invitrogen), and 10 % fetal bovine serum (FBS) (Lonza, Walkersville, MD, USA). All cells were cultured at 37 °C in a 5 % CO2 environment, and the cellular medium was changed every 2–3 days. Cells were passaged upon reaching 80 % confluence, and all experiments were performed using cells at passage eight or lower. Then, to induce FC differentiation, THP-1 cells were incubated with 10−7 M phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich) for 48 h, followed by incubation with 80 μg/mL oxLDL (Intracel Resources, Frederick, MD, USA) for 0, 6, 24, 48, and 72 h to form foam cells at differential stages.
Oil red staining
To identify the lipid acumination at different stages of foam cell formation, after incubation with oxLDL for 0, 6, 24, 48, or 72 h, THP-M were stained with Oil Red (Sigma-Aldrich, MO, USA) for 10 min at RT. The Oil Red staining allowed for visualization and imaging of FC containing intracellular lipid droplets via a Leika microscope (Nikon Inc., Melville, NY, USA) at an objective magnification of 20×. The cells were photographed with a Coolsnap ES camera (Photometrics, Tucson, AZ, USA), using Simple PCI image capture software (Hamamatsu Corporation, Sewickley, PA, USA).
Cell viability was measured by the MTT assay (M5655, Sigma-Aldrich, Inc., Saint Louis, MO, USA), based on the MTT conversion into formazan crystals via the action of mitochondrial dehydrogenases. Briefly, THP-M-derived foam cells were plated at a density of 2.5 × 104 cells/cm2 in 96-well plates. After the treatment, the culture medium was replaced with 200 μL of MTT solution (5 mg/mL stock solution in PBS, diluted with culture medium to the final concentration 0.5 mg/mL). After 4-h incubation at 37 °C, this solution was removed, and the produced formazan was solubilized in 150 μL dimethyl sulfoxide (DMSO). The absorbance was measured at 570 nm through an automated microplate reader (Tecan Infinite 200 pro microplate reader, Männedorf, Switzerland). Cell viability was calculated by comparing the results to those of the control cells, which were considered 100 % viable.
Detection of apoptosis and mitochondrial superoxide production was performed as previously described (17). Samples were analyzed using a BD FACSCanto II flow cytometer (BD Biosciences, CA, USA). For Annexin V-FITC/PI staining, the maximum FITC excitation wavelength/emission wavelength was 488 nm/525 nm, and the maximum PI excitation wavelength/emission wavelength was 535 nm/615 nm, respectively. A number of 10,000 events were collected for each sample. The CellQuest software (Becton Dickinson, San Jose, CA, USA) was used to analyze the data obtained.
mRFP-GFP-LC3 plasmid construction and transfection
Microtubule-associated protein light chain 3 (LC3) is an ubiquitin-like protein that binds to autophagosomes (AVs). Typically, mammalian cells are transfected with GFP-tagged LC3 to track and follow the fate of AVs in the cell and to measure the autophagic flux. Here, we used an adenovirus (Ad-LC3-GFP-mRFP) expressing the GFP and mRFP fluorescent proteins for marking and tracking LC3 (HANBIO, Shanghai, China). In brief, 1640 medium (containing 10 % FBS) was employed to culture THP-1 cells which were incubated with the Ad-LC3-GFP-mRFP adenovirus for two hours to be infected. Then, the culture medium was replaced and the incubation continued for 36 h. Counting of autophagosomes and autolysosomes was performed on a Thermo Scientific Cellomics ArrayScan HCS reader (Thermo Fisher Scientific, Pittsburgh, PA, USA) (20x objective) using the Spot detector V3 Cellomics Bioapplication (Cellomics, USA.) GFP and RFP vesicles were identified on separate secondary channels by FITC- and Texas Red-associated filters, respectively, depending upon size, shape, and intensity thresholding. The mean number of vesicles per cell (object) was calculated by the ArrayScan software, as the total number of vesicles per field was divided by the total number of objects per field. One thousand cells were counted per coverslip, and the analysis was conducted on triplicate samples at least twice. The yellow spots and red spots after overlapping represented autophagosomes and autolysosomes, respectively. Through counting the different color spots, we determined the presence of autophagy in the different groups.
Measurement of mitochondria oxidative stress
Mitochondria-derived superoxide anion in THP-M cells of different stages was determined quantitatively by an ELISA method based on Mito SOX (Molecular Probes), according to the manufacturer’s protocol. Superoxide anion generation was also established semi-quantitatively by fluorescence intensity as detected by the Image-Pro Plus software in conjunction with a Leica Confocal microscope.
Aliquots of 20 mg of protein extracts from human THP-1 macrophages were separated by 10 % sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and subjected to immunoblotting with the following antibodies LC3B (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and P62, GAPDH (1:1000) [16–19]. The densities of the bands were measured using a Densitograph System (Ez-Capture II and CS Analyzer 3.0, ATTO, Tokyo, Japan), and the ratio to GAPDH was calculated.
The animal experiments were approved by the Institutional Animal Care and Use Committee of Fuwai Hospital (Permission No. 2013-6-40-GZR). A total of 24 8-week-old male spontaneously hyperlipidemic ApoE−/− mice were purchased from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC) and fed with a high-fat rodent diet containing 21 % fat from lard and supplemented with 0.15 % (wt/wt) cholesterol (Special Diets Services) until 16 weeks of age (18). At that age, 24 mice were allocated by body weight and plasma total cholesterol levels into three groups (10 animals/group): the vehicle group, the Rapa group, and the 3-MA group. The animals were administered either the vehicle or the respective drug by i.p. route once a day for 6 weeks.
Intravascular ultrasonic imaging
Mice were anesthetized using 10 % chloral hydrate (3 mL/100 g). Echocardiography was performed with a Vevo2100 ultrasound system (VisualSonics Inc., Toronto, Canada) and a MS400 transducer. Intravascular ultrasonic imaging was conducted to compare the effect of autophagy on plaque formation. Echocardiograms were interpreted by two separate cardiologists who were blinded to the animal groups.
Histologic examination of atherosclerosis
At 24 weeks of age, ApoE−/− mice were anesthetized with diethyl ether. The aortic root was carefully excised and fixed with 4 % formaldehyde and 10 % sucrose. The sections were stained with hematoxylin-eosin (HE) and oil red O to measure the total lesion area. The degree of intimal thickening was evaluated as previously described (14). Briefly, the lesion area of the intima and the luminal circumference of the media in the oil red-stained section were measured by an image analyzer. The intimal thickness (mm) was then calculated by dividing the intimal lesion area by the luminal circumference of the media. The cellular components of the atherosclerotic lesion in the thoracic aorta lesion were examined immunohistochemically by the streptoavidin method (LSAB Kit, Dako Japan Co, Ltd, Tokyo, Japan) using an anti-macrophage antibody (MOMA-2) as the primary antibody and a biotin-labeled anti-mouse IgG antibody and a biotin-labeled anti-sheep IgG antibody (MBL Co, Ltd, Nagoya, Japan) as the secondary antibodies, respectively. The following parameters were measured: plaque cross-sectional area, media cross-sectional area, percentage of occlusion of the lumen by plaque, the number of buried fibrous caps, current fibrous cap thickness, and percentage of lipid content of the plaque. An assessment of the oxidative stress in aortic root frozen-tissue sections was performed by fluorescence microscopy of dihydroethidium (DHE)-stained sections as previously described .
Statistical significance was calculated via the unpaired Student’s t-test between two groups and 1-way ANOVA, followed by the Bonferroni’s post-hoc test among multiple groups by the Statview J-5.0 software (SAS Institute, Cary, NC, USA). A value of P < 0.05 was considered to be statistically significant. All values were expressed as the mean ± standard error of the mean (SEM).
Assessment of lipid content and cell viability during the course of macrophage-derived foam cells formation and progress
Assessment of autophagy changing manner during macrophage-derived foam cell formation and progress
Autophagy is dynamic and encompasses autophagosome formation, cargo sequestration, and eventual lysosomal fusion/degradation occurring in rapid succession. To explore the involvement and manner of action of autophagy in the process of foam cell formation, we used Western blotting and mRFP-GFP-LC3 adenovirus infection to determine the amounts of autophagosomes and autophagic flux at different stages of foam cell progression, respectively.
Autophagy affects the fate of macrophage-derived foam cells
Many studies have provided evidence that autophagosomes exist in different stages of AS, indicating the involvement of autophagy in AS occurrence and development. However, the feasibility of autophagy as the target of treating AS is debated. One of the reasons may be that the effects of the same agent on different stages of foam cells formation are significantly different . Therefore, according to the above results, we respectively selected early 6 and 48 h as regulatory “Key points” of foam cells life cycle to explore the effect of autophagy on the fate of THP-M-derived foam cells.
During the process of foam cell progress, THP-M was co-cultured with oxLDL for 48 h. As shown in Fig. 3, Rapa not only reduced significantly the lipid content in the cytoplasm (downside panel in Fig. 3a, b), but also increased the viability of mid-late-THP-M derived foam cells (Fig. 3d, e). To determine if the inhibition of macrophage autophagy affected the fate of mid-late THP-M-derived foam cells, we treated THP-M with autophagy inhibitor 3-MA. Not only was the lipid content increased, but also cell viability was significantly impaired, suggesting the fate of THP-M-derived foam cells was associated with autophagy.
Autophagy influenced atherosclerotic lesion area and stability
To determine which cells in atherosclerotic plaques express autophagy markers, we characterized ApoE−/− atherosclerotic aortic roots by immunofluorescence. The autophagy markers LC3 (Fig. 4c) were concurrently imaged with MOMA-2 (an antibody that recognizes monocyte-macrophages). These results indicated that monocytes/macrophages were the predominant cell type expressing autophagy markers in the plaque and were likely responsible for progressive autophagy deficiency. The TUNEL assay (Fig. 4d) showed that the apoptotic cell number in the rapa-treated group was considerably lower than that in the control group, indicating that Rapa can prevent mid-staged AS from plaque progression and enhance the stability of plaques.
Potential mediators of autophagy biological effect
In the present study, for the first time, we clarified the changing pattern and function of autophagy in the development and progress of macrophage-derived foam cells and validated the hypothesis that in middle-late foam cells, autophagy was restrained, intracellular accumulation of lipid droplets and mitochondria clearance impaired, and a large number of reactive oxygen species generated. Cell viability decreased, which may be the most important factor that contributed to plaque progress and instability, autophagy may be a potential target for AS treatment. Therefore, our study has discovered a novel perspective to understand the mechanism of plaque stability and provides a clue for developing comprehensive methods for diagnosis and treatment of AS.
Autophagy is dynamic and has also been shown to be directly involved in lipid homeostasis [23, 24]. This type of autophagy, called lipophagy, was first found in the liver and has now become a subject of intense research interest with potentially profound implications for the treatment of the diseases associated with dyslipidemias, such as diabetes and atherosclerosis [25, 26]. In this examination, to clarify the changing pattern and function of autophagy in AS, THP-1 macrophage was induced with ox-LDL (80 μg/mL) into different stages of foam cell models. When cocultured with ox-LDL for 6–72 h, THP-M cell morphology and lipid content were in line with the characteristics of foam cells at the early stage, middle stage, or late stage. After 48 h, irreversible death occurred in a large number of foam cells. Therefore, in this study, 6 or 48 h were selected as optimal time points to regulate autophagy and investigate its effect.
It is well known that the autophagy process includes autophagosome formation, cargo sequestration, and eventual lysosomal fusion/degradation occurring in rapid succession. Autophagosome-lysosomal fusion is the essential step. LC3-II is a relatively sensitive biochemical marker of autophagy. Ad-LC3-GFP-mRFP is a reporter system. LC3 is distributed in the cytoplasm under normal conditions (LC3-I), but when autophagy is induced, LC3-I is modified to become LC3-II, which is integrated into the autophagosome membrane . In the early-staged foam cells, with prolonged oxLDL incubation time, autophagosomes continued to increase, and the autophagic flux intensity was gradually enhanced, characterized by an increased proportion of LC3II/I and percentage of mRFP-positive cells. When THP- M cells were incubated with oxLDL and Rapa for 6 h, the oil red staining assay results showed that the lipid deposition in cells was limited, and while intracellular autophagosome and autophagy-lysosome quantity increased gradually, the cell membrane remained intact. When oxLDL and THP-M interaction lasted beyond 6 h, autophagy was restrained; the deposition of lipid droplets in cells increased obviously, and the rapa treatment at this stage not only corrected the dysfunctional autophagy and decreased the formation rate of foam cells.
Komatsu et al. found that homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy deficient mice. p62, a chaperone that shuttles intracellular protein aggregates into autophagosomes for degradation, has emerged as a useful marker of autophagic status [27–30]. Since the entire p62/SQSTM1-protein aggregate complex is degraded after engulfment by the autolysosome, p62 level is inversely correlated with autophagic flux, i.e., the increases of p62 level indicate defective autophagy [29, 30]. Our results also showed that P62 level decreased at the early stage of foam cell formation. Published evidence supports this possibility. The cells in atherosclerotic plaques develop progressive lysosomal dysfunction with features resembling a lysosomal storage disease . The accumulation of unhydrolyzed cholesteryl esters and trapped/poorly translocated free cholesterol in lysosomes has been described in macrophage foam cells [32–37]. These unmetabolized substituents may impair the lysosomal degradation capacity of lipases and other enzymes, including proteases. Our observation that p62 accumulates in the advanced atherosclerotic plaques is consistent with this concept and verify that autophagy is inhibited in advanced plaques.
The general consensus on the function of autophagy is that in contrast to basal autophagy, the excessive stimulation of autophagy may cause autophagic cell death. This is logical since both autophagy and cell death may be activated in response to similar stress conditions [38, 39]. Therefore, the proper regulation of autophagy at the right time point is important. Facing the inhibited autophagy in advanced atherosclerotic plaque, an important question exists whether it is feasible to consider autophagy as an intervention target?
In this study, we fed Apo E −/− mice (known to be susceptible to atherosclerosis) with a Western diet for 16 weeks (middle phase of spontaneous AS) and treated them with an autophagy stimulator (Rapa) or autophagy inhibitor (3-MA) for 8 weeks. Then, assessments were performed of plaque area/stability, the types of inflammatory cells infiltration, ROS levels, and cell viability in the aortic roots of mice in the different groups.
According to our results, upregulation of autophagy to its normal level did decrease the apoptosis rate in mid-late phase THP-M foam cells and suppress the atheroma progression. However, what is the nature of this action? We found that the autophagic removal of damaged mitochondria (also called mitophagy) was enhanced, and, in turn, reduced reactive oxygen species (ROS) production. It has been demonstrated that release of ROS and DNA from damaged mitochondria can activate inflammasomes, a process that contribute to plaque formation and progression [22, 40]. Therefore, the possible mechanism of the protective effect of rapa is through upregulation of autophagy and decrease of mitochondrial ROS. On the other hand, the observation that plaques treated with the autophagy inhibitor 3-MA increased the levels of markers of protein oxidation and superoxide production lends credence to this possibility.
There were several limitations of this study. This work was focused on studying the function of autophagy on the fate of macrophage-derived foam cells and exploration of the most relevant intervention time. Although we have used the respective autophagy agonists and inhibitors to observe the effect of autophagy on the foam cell development in Ox-LDL-treated THP-1 macrophages or the progress of atherosclerotic plaques in high fat diet Apo E −/− mice, we did not use foam cells derived from vascular smooth muscle cells, which are also important for atherosclerosis plaque formation and maintenance of the stability of atherosclerotic lesions. In addition, if macrophage-specific autophagy defects in mice can be used to repeat and further develop the preliminary findings of this study in the future, the results would be more persuasive and convincing.
The fate of macrophage FCs was associated with autophagy. Autophagy might be a promising intervention target for AS treatment.
DHE, dihydroethidium; FC, foam cell; LC3, microtubule-associated protein light chain 3; oxLDL, oxidized low-density lipoprotein LDL; PMA, phorbol 12-myristate 13-acetate; ROS, reactive oxygen species
This work was sponsored by Natural Science Foundation of China (Project No. 81200213) and National High-tech R&D Program (863 Program) (Project No. 2012AA022403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
All the data and material can be available.
CYC conceived and coordinated the study and wrote the paper. LXP performed and analyzed the experiments. ZH and ZD performed and analyzed the experiments shown in Fig. 3. TY provided technical assistance. All authors reviewed the results and approved the final version of the manuscript.
The authors have declared that no competing interests exist.
Consent for publication
Ethics approval and consent to participate
This research project was approved by the Institutional Animal Care and Use Committee of Fuwai Hospital (Permission No. 2013-6-40-GZR). All treatments were carried out in accordance with the Institutional Animal Care and Use Committee of Fuwai hospital and followed national guidelines for the treatment of animals.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–41. doi:10.1016/j.cell.2011.10.026.View ArticlePubMedGoogle Scholar
- Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12(9):814–22. doi:10.1038/ncb0910-814.View ArticlePubMedPubMed CentralGoogle Scholar
- Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42. doi:10.1016/j.cell.2007.12.018.View ArticlePubMedPubMed CentralGoogle Scholar
- Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007;13(5):619–24. doi:10.1038/nm1574.View ArticlePubMedGoogle Scholar
- Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880–4. doi:10.1038/nature04723.View ArticlePubMedGoogle Scholar
- Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069–75. doi:10.1038/nature06639.View ArticlePubMedPubMed CentralGoogle Scholar
- Sridhar S, Botbol Y, Macian F, Cuervo AM. Autophagy and disease: always two sides to a problem. J Pathol. 2012;226(2):255–73. doi:10.1002/path.3025.View ArticlePubMedGoogle Scholar
- Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469(7330):323–35. doi:10.1038/nature09782.View ArticlePubMedPubMed CentralGoogle Scholar
- Kockx MM, De Meyer GR, Buyssens N, Knaapen MW, Bult H, Herman AG. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res. 1998;83(4):378–87.View ArticlePubMedGoogle Scholar
- Martinet W, De Meyer GR. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res. 2009;104(3):304–17. doi:10.1161/circresaha.108.188318.View ArticlePubMedGoogle Scholar
- Martinet W, De Bie M, Schrijvers DM, De Meyer GR, Herman AG, Kockx MM. 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24(12):2296–301. doi:10.1161/01.ATV.0000146266.65820.a1.View ArticlePubMedGoogle Scholar
- Razani B, Feng C, Coleman T, Emanuel R, Wen H, Hwang S, et al. Autophagy links inflammasomes to atherosclerotic progression. Cell Metab. 2012;15(4):534–44. doi:10.1016/j.cmet.2012.02.011.View ArticlePubMedPubMed CentralGoogle Scholar
- Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 2012;15(4):545–53. doi:10.1016/j.cmet.2012.01.022.View ArticlePubMedPubMed CentralGoogle Scholar
- Martinet W, De Meyer GR. Autophagy in atherosclerosis. Curr Atheroscler Rep. 2008;10(3):216–23.View ArticlePubMedGoogle Scholar
- Schrijvers DM, De Meyer GR, Martinet W. Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arterioscler Thromb Vasc Biol. 2011;31(12):2787–91. doi:10.1161/atvbaha.111.224899.View ArticlePubMedGoogle Scholar
- Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, Listenberger LL, et al. Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab. 2011;14(1):33–44. doi:10.1016/j.cmet.2011.04.009.View ArticlePubMedPubMed CentralGoogle Scholar
- Clarke PG, Puyal J. Autophagic cell death exists. Autophagy. 2012;8(6):867–9. doi:10.4161/auto.20380.View ArticlePubMedPubMed CentralGoogle Scholar
- Pang J, Fuller ND, Hu N, Barton LA, Henion JM, Guo R, et al. Alcohol Dehydrogenase Protects against Endoplasmic Reticulum Stress-Induced Myocardial Contractile Dysfunction via Attenuation of Oxidative Stress and Autophagy: Role of PTEN-Akt-mTOR Signaling. PLoS One. 2016;11(1):e0147322. doi:10.1371/journal.pone.0147322. eCollection 2016.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang X, Qi H, Wang Q, Zhu Y, Wang X, Jin M, et al. FGFR3/fibroblast growth factor receptor 3 inhibits autophagy through decreasing the ATG12-ATG5 conjugate, leading to the delay of cartilage development in achondroplasia. Autophagy. 2015;11(11):1998–2013.View ArticlePubMedGoogle Scholar
- Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab. 2011;13(6):655–67. doi:10.1016/j.cmet.2011.03.023.View ArticlePubMedPubMed CentralGoogle Scholar
- Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev. 2011;243(1):136–51. doi:10.1111/j.1600-065X.2011.01046.x.View ArticlePubMedGoogle Scholar
- Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med. 2011;208(3):417–20. doi:10.1084/jem.20110367.View ArticlePubMedPubMed CentralGoogle Scholar
- Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131–5. doi:10.1038/nature07976.View ArticlePubMedPubMed CentralGoogle Scholar
- Singh R. Autophagy and regulation of lipid metabolism. Results Probl Cell Differ. 2010;52:35–46. doi:10.1007/978-3-642-14426-4_4.View ArticlePubMedPubMed CentralGoogle Scholar
- Xu G, Watanabe T, Iso Y, Koba S, Sakai T, Nagashima M, et al. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis. Circ Res. 2009;105(5):500–10. doi:10.1161/circresaha.109.193870.View ArticlePubMedGoogle Scholar
- Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, Sakai T, et al. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation. 2008;117(5):638–48. doi:10.1161/circulationaha.107.712539.View ArticlePubMedGoogle Scholar
- Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005;171(4):603–14. doi:10.1083/jcb.200507002.View ArticlePubMedPubMed CentralGoogle Scholar
- Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008;4(2):151–75.View ArticlePubMedGoogle Scholar
- Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131(6):1149–63. doi:10.1016/j.cell.2007.10.035.View ArticlePubMedGoogle Scholar
- Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137(6):1062–75. doi:10.1016/j.cell.2009.03.048.View ArticlePubMedPubMed CentralGoogle Scholar
- Jerome WG. Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder. Rejuvenation Res. 2006;9(2):245–55. doi:10.1089/rej.2006.9.245.View ArticlePubMedGoogle Scholar
- Brown AJ, Mander EL, Gelissen IC, Kritharides L, Dean RT, Jessup W. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. J Lipid Res. 2000;41(2):226–37.PubMedGoogle Scholar
- Dhaliwal BS, Steinbrecher UP. Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally. J Lipid Res. 2000;41(10):1658–65.PubMedGoogle Scholar
- Griffin EE, Ullery JC, Cox BE, Jerome WG. Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells. J Lipid Res. 2005;46(10):2052–60. doi:10.1194/jlr.M500059-JLR200.View ArticlePubMedGoogle Scholar
- Jessup W, Mander EL, Dean RT. The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. Biochim Biophys Acta. 1992;1126(2):167–77.View ArticlePubMedGoogle Scholar
- Lougheed M, Zhang HF, Steinbrecher UP. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J Biol Chem. 1991;266(22):14519–25.PubMedGoogle Scholar
- Yancey PG, Jerome WG. Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux. J Lipid Res. 2001;42(3):317–27.PubMedGoogle Scholar
- Shen S, Kepp O, Michaud M, Martins I, Minoux H, Metivier D, et al. Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene. 2011;30(45):4544–56. doi:10.1038/onc.2011.168.View ArticlePubMedGoogle Scholar
- Lindqvist LM, Heinlein M, Huang DC, Vaux DL. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak. Proc Natl Acad Sci U S A. 2014;111(23):8512–7. doi:10.1073/pnas.1406425111.View ArticlePubMedPubMed CentralGoogle Scholar
- Park SJ, Jeon YJ. Dieckol from Ecklonia cava suppresses the migration and invasion of HT1080 cells by inhibiting the focal adhesion kinase pathway downstream of Rac1-ROS signaling. Mol Cells. 2012;33(2):141–9. doi:10.1007/s10059-012-2192-6.View ArticlePubMedPubMed CentralGoogle Scholar